cerrar
Tagged with investment,

Ireland: up the ladder
Lilly set up in Ireland three decades ago by purchasing a farm. In its early days, the operation produced intermediaries for small-molecule drugs.…

From foreign investment, Irish companies
FDI into Ireland has created a feedstock for the indigenous ecosystem: raising the bar for standards and technology, contributing to the experience of…

Interview: Thomas Willemsen, Vice President and General Manager,…
In Taiwan, GSK recently signed Memorandum of Understanding with the National Research Program of Biopharmaceuticals (NRPB), building on research…

Interview: Pia Olsen Dyhr, Minister of Trade & Investment,…
Pia Olsen Dyhr is a member of the Danish Folketing (Parliament) for the Socialist People’s Party in the North Zealand greater constituency, as well…

Interview: Jacques Dessureault, President and General Manager,…
With a Master’s Degree in Marketing Science from the University of Leicester and a Degree in Management Information Systems from Université du…

Interview: Dr. Philippe Douville, President and CEO, Milestone…
Dr. Douville talks investment, the company's role in R&D in Canada and their plans for some of their future products.

Teresa Bitetti – General Manager, BMS Canada
Teresa Bitetti has a long history with BMS, spanning 3 decades in which she rose up the ranks starting from Senior Director of Abilify Marketing…

Interview with Michael Brogan, President, IMS Brogan, Canada
Mike Brogan, before taking up the mantle of President at IMS was VP of Business Integration at IMS for a year. Today, he talks about the difficulties…

Interview with Dr. Fernand Labrie CEO, EndoCeutics, Canada
Dr. Fernand Labrie, long before becoming CEO of EndoCeutics, discovered and developed medical castration with GnRH agonists, a breakthrough treatment…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here